What Happened?
Shares of medical device company LeMaitre Vascular (NASDAQ: LMAT) jumped 16.8% in the morning session after the company reported strong fourth-quarter 2025 results that surpassed Wall Street's expectations for both revenue and earnings. The medical device provider posted sales of $64.45 million, a 15.7% increase from the same period in the previous year. Earnings per share (EPS) grew significantly to $0.68, up from $0.49 in the prior year's quarter and beating analyst forecasts. The company's profitability also saw a notable lift, with its operating margin expanding to 29.2% from 23.1% a year ago. Looking ahead, LeMaitre offered a bright outlook, providing first-quarter revenue guidance that was ahead of consensus and a full-year 2026 GAAP EPS forecast of $2.91 at the midpoint, which was well above market predictions.
Is now the time to buy LeMaitre? Access our full analysis report here, it’s free.
What Is The Market Telling Us
LeMaitre’s shares are not very volatile and have only had 6 moves greater than 5% over the last year. Moves this big are rare for LeMaitre and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was 10 months ago when the stock dropped 12.2% on the news that the company reported weak first quarter 2025 results with a significant miss on full-year EPS guidance and underwhelming EPS guidance for next quarter. On the other hand, LeMaitre's full-year revenue guidance topped analysts' expectations and organic revenue outperform Wall Street's estimates. Still, this was a weaker quarter.
LeMaitre is up 36.4% since the beginning of the year, and at $109.39 per share, has set a new 52-week high. Investors who bought $1,000 worth of LeMaitre’s shares 5 years ago would now be looking at an investment worth $2,129.
Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free and will only take you a second.
